Greenlane Holdings, Inc. GNLN, a global leader in cannabis accessories and vaporization products, reported its financial performance Monday for the second quarter concluding on June 30th, 2023.
The company reported a decline in revenue for Q2 2023, with figures dropping to $19.6 million, in comparison to the $24.0 million achieved in Q1 2023.
Despite this, operating expenses in Q2 2023 saw a reduction of $0.9 million, marking a 6.2% decrease when compared with Q1 2023.
"We're focused on profitability, enhancing innovation, and eliminating $15M debt," stated Craig Snyder, Greenlane CEO. "In Q2, substantial expense reduction progress continued, consolidating eight facilities, including Verst, saving over $4M annually, enhancing customer experience. Similar initiatives in Technology and Professional Services for ongoing savings."
Net Loss And EBITDA Trends
- Greenlane recorded a net loss of $10.5 million in Q2 2023, marginally surpassing the $10.2 million loss reported in Q1 2023.
- Basic and diluted net loss per share amounted to $6.56, slightly higher than the previous quarter's loss of $6.40 per share.
- The company's adjusted EBITDA loss for Q2 2023 stood at $5.8 million, a reduction from the $6.8 million loss reported in Q1 2023.
- Although experiencing a decrease in net sales for the quarter, Greenlane Holdings, Inc. maintained a gross margin of 23.3%, consistent with the first quarter of 2023.
Price Action
GNLN stocks were trading lower by 4.38% at $0.851 per share after market close.
The Benzinga Cannabis Capital Conference, the place where deals get done, is returning to Chicago this Sept 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.
Photo: Rudy and Peter Skitterians via Pixabay.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.